Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subscribe to Newsletter

Discovery & Development

Discovery & Development Drug Discovery

Down with the Resistance

Are all antibiotics doomed to eventual impotence? New work from Oxford could change the game by defeating resistance itself.

Discovery & Development Drug Discovery

A Little Byte of Life

Thorben Seeger wants to democratize the data held by the world’s leading genomic institutions. But what exactly does he mean by “democratize”?

Discovery & Development Drug Discovery

Anthrax: an Unlikely Ally

| Angus Stewart

Boston bioscientists have found an unlikely ally in anthrax toxins, which could form the basis for a new kind of painkiller.

Discovery & Development Business Practice

“We Want to Return to the Lab”: How the Russian Invasion Has Disrupted Drug Discovery in Ukraine

| Angus Stewart

The Russian invasion of Ukraine will disrupt and displace a great deal of work in drug discovery. Here’s why.

Discovery & Development Digital Technologies

A Pain-Free Reality

| Stephanie Sutton

Enter the world of immersive therapeutics – where VR is being explored as an alternative to traditional medicines for pain.

Discovery & Development Drug Delivery

Prodrugs Assemble

Work by an international team in Japan has found a new and effective way to attack cancer inside the body.

Discovery & Development Drug Discovery

Seeing the Value of Nano

| Christian Jones

Find out how nanotechnology can overcome challenges in drug delivery to the eye.

Discovery & Development Analytical Science

Top Tips for mRNA Sequencing

We explore the potential of mRNA as therapeutics and the challenges associated with analysis and sequencing.

Discovery & Development Ingredients

Video: Why Does Pharma Need Novel Excipients?

With so many new dosage forms being seen in pharma, a problem is emerging: the need for novel excipients. Watch our video to learn more.

Discovery & Development Drug Discovery

The Cell Reprogrammer

We sit down to interview Louise Modis, Chief Scientific Officer at Mogrify, UK, about her career and role at the company.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register